��������

Andres Gagete, PhD has more than a decade of experience in the biotech and academic sectors. Prior to Artax, Dr. Gagete was the Innovation Director for Bioncotech Therapeutics. He is currently coordinating R&D and operations for Artax, including leadership of program management. Dr. Gagete has held post-doc research positions at the Spanish National Cancer Center (CNIO) and “Principe Felipe” Research Center (CIPF) in Valencia, Spain. Dr. Gagete holds a BSc in Biochemistry and a PhD in Molecular Biology from the University of Valencia.